| Labcorp

September 20, 2022

Utilizing health economic insights to inform product development and secure market access

We are your source for strategic HEOR services to support successful market access activities. A winning market access strategy requires early and ongoing consideration of the health economic and outcomes research (HEOR) needs for your product.

September 22, 2022

Characterizing the effector functions of therapeutic antibodies

Understand the Fc region of your antibody product, so that you can assess the impact on immunology, safety and efficacy. Using a risk-based approach, find out the most efficient way to test functionality relevant to the stage of drug development.

September 26, 2022

Released N-Glycan Analysis of the Fc-Fusion Protein Aflibercept with Additional Site-Specific Population and Occupancy Analysis

CASSS MS 2022 -- Glycosylation is a common PTM and is formed during the production and manufacture of a therapeutic product. Glycans play a significant role in therapeutic proteins and require confident quantitative analysis.

September 26, 2022

Assessment of Immunogenicity in SARS-CoV-2 Naïve and Convalescent Subjects Following COVID-19 Vaccination

WRIB 2022 -- Active vaccination leads to successful priming of adaptive immune responses, resulting in the development of antigen-specific T and B effector cells. Upon encountering the same antigen (by booster vaccine or exposure to infection), these effector lymphocytes proliferate and undergo clonal expansion and differentiation.

October 10, 2022

Designing a high-touch, low-burden pediatric vaccine study with powerful digital solutions

Labcorp's diligence in engaging investigator sites, providing comprehensive decentralized solutions accommodating the stretch timeline goals has helped the sponsor to run this powerful pediatric vaccine study. Labcorp Drug Development impressed the sponsor with a range of powerful digital solutions.

October 10, 2022

Developing a fully integrated DCT platform to simplify operations in global clinical trials

Labcorp Drug Development offered in-house, fully integrated DCT capabilities, the sponsor came to us for solutions. Specifically, the sponsor wanted greater flexibility in trial conduct.

October 19, 2022

Harness our global clinical experience in cardiovascular development

We're committed to advancing your cardiovascular study with the best resources, from our in-house cardiology specialists to our vast global clinical trial data insights.

October 20, 2022

How Labcorp Mobile Clinical Services may improve the patient experience in oncology studies

Labcorp MCS is a suite of solutions that aims to reduce the patient burden of studies while also providing flexibility to the investigator sites.

October 23, 2022

A Program to Address Compassion Fatigue in a Large Contract Research Organization

National AALAS 2022 -- Compassion fatigue is a common occurrence in the fields of veterinary medicine and animal testing, such that most workers have been impacted either directly or indirectly. Animal euthanasia, night work, weekend/holiday work and challenging study designs are some examples of things that can cause compassion fatigue.

October 23, 2022

Snuggle Your Bunnies! An Alternative to Manual Restraint for Rabbit Gavage, Intravenous Injection and Ear Vessel Blood Collection

National AALAS 2022 -- Restraining a rabbit for various dosing routes and blood collection can be difficult with a myriad of items needing to be considered; from the animal's fragility to their ability to kick and injure technicians, and technician safety to animal welfare.

管理您的健康

疾病与治疗领域

治疗模式与方法

科学实验室学科

实验室

行业